362
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Certolizumab pegol in the treatment of Crohn's disease

, MD PhD, , MD PhD & , MD PhD FRCP
Pages 595-605 | Published online: 04 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Teodora-Ecaterina M Manuc, Mircea M Manuc & Mircea M Diculescu. (2016) Recent insights into the molecular pathogenesis of Crohn’s disease: a review of emerging therapeutic targets. Clinical and Experimental Gastroenterology 9, pages 59-70.
Read now
Alfredo Adán, Marina Mesquida & Victor Llorenç. (2013) Biologic drugs in noninfectious uveitis: an update. Expert Review of Ophthalmology 8:5, pages 501-516.
Read now

Articles from other publishers (2)

Yun-Na Song & Ping Zheng. (2015) Efficacy and safety of tumor necrosis factor-α blockers for ulcerative colitis: A systematic review and meta-analysis of published randomized controlled trials. Journal of Food and Drug Analysis 23:1, pages 1-10.
Crossref
Lawrence B. Cohen, Radu M. Nanau, Faustine Delzor & Manuela G. Neuman. (2014) Biologic therapies in inflammatory bowel disease. Translational Research 163:6, pages 533-556.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.